Verbatim response from ChatGPT
Short answer: Many telehealth primary-care and weight‑management services will evaluate you for a GLP‑1 (semaglutide) and — if a clinician thinks it’s appropriate and legal in your state — can prescribe it or a related product. However, Ozempic (semaglutide) is FDA‑approved for type 2 diabetes; providers often won’t prescribe it for prediabetes alone and may prefer a weight‑management product such as Wegovy or alternative agents. Expect a medical review, possible labs (A1c, kidney tests, pregnancy test if applicable), and state‑by‑state restrictions.
Online services that commonly offer semaglutide/GLP‑1 programs (examples to look into)
- PlushCare — national telemedicine primary‑care and endocrinology visits; clinicians can prescribe diabetes and weight‑loss medications where appropriate and deliver prescriptions to your pharmacy.
- Ro (roman.com / Ro) — offers virtual weight‑management and chronic‑care programs that have included semaglutide/GLP‑1 prescribing and home delivery.
- Hims & Hers (forhims.com / hims.com / hers.com) — DTC telehealth platform offering evaluation and prescriptions for semaglutide/tirzepatide for weight management in eligible patients.
- Lemonaid Health (lemonaidhealth.com) — low‑cost telemedicine service that in many states prescribes GLP‑1s for weight management and metabolic care after virtual evaluation.
- Form Health (formhealth.com) — specialty virtual obesity clinic that frequently prescribes GLP‑1s as part of structured weight‑loss programs.
- Profile by Sanford (profileplan.com) — clinic/telehealth weight‑loss program offering anti‑obesity medications, including semaglutide, with monitoring and coaching.
What to expect and important cautions
- You’ll need a telehealth visit and medical history; many services require recent labs. Providers may decline to prescribe if they don’t judge it clinically appropriate for prediabetes.
- Ozempic is labeled for type 2 diabetes; Wegovy is the higher‑dose semaglutide product approved for chronic weight management. Some services prescribe “semaglutide” (off‑label or as other brand formulations) or alternative agents (tirzepatide/Mounjaro/Zepbound).
- Insurance coverage varies widely — diabetes indications are more likely to be covered than weight‑loss indications. Ask the service and your insurer about coverage and cost.
- Do not buy injectable semaglutide from unverified marketplaces or international sources — there are safety and authenticity risks.
If you’d like I can:
- Look up which of these services currently treat patients in your state,
- Suggest questions to ask during a telehealth visit, or
- Help you decide whether to pursue a GLP‑1 evaluation vs seeing a PCP/endocrinologist in person. Which would you prefer?